<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
----------
Date of Report (Date of earliest event reported): APRIL 2, 1998
IBIS TECHNOLOGY CORPORATION
------------------------------------------------------
(Exact name of registrant as specified in its charter)
MASSACHUSETTS 0-23150 04-2987600
- --------------- ------------ -------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
32 CHERRY HILL DRIVE, DANVERS, MASSACHUSETTS 01923
-------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (978) 777-4247
<PAGE> 2
ITEM 5. OTHER EVENTS.
On April 2, 1998, the Registrant publicly disseminated a press release
announcing that Dr. Julian G. Blake has joined the Registrant as Director of
Technology. Dr. Blake has had an extensive career in ion implanter development
and advanced physics. During his 15 year tenure at Eaton Corporation, Dr. Blake
was Technical Director at the Eaton Flat Panel Division and Chief Scientist at
the Semiconductor Equipment Operations. In addition, Dr. Blake managed the
engineering and applications departments at Eaton. He also served as Principal
Investigator for a $2,000,000 Air Force contract researching SIMOX SOI
technology and directed a low energy SIMOX development program. Dr. Blake has
served on the National Science Foundation Site Visit Committee (NCSU) and the
National Research Council (NAMAB), and holds seven U.S. patents. Prior to
joining Eaton Corporation, Dr. Blake worked for Exxon Solar Power Corporation
where he was responsible for the development of new solar cell manufacturing
processes. Dr. Blake received his Ph.D. in Applied Physics from Harvard
University in 1973 and then spent eight years with Harvard in various capacities
ranging from Physics lecturer to Director of the Gordon McKay Laboratory. The
information contained in the press release is incorporated herein by reference
and filed as Exhibit 99.1 hereto.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibit.
99.1 The Registrant's Press Release dated April 2, 1998.
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IBIS TECHNOLOGY CORPORATION
(Registrant)
Date: April 3, 1998 /s/ Debra L. Nelson
--------------------------------
Debra L. Nelson, Chief Financial
Officer
3
<PAGE> 4
EXHIBIT INDEX
Exhibit Sequential
Number Description Page Number
- ------- ----------- -----------
99.1 The Registrant's Press Release 5
dated April 2, 1998
4
<PAGE> 1
[IBIS TECHNOLOGY CORPORATE LOGO]
CONTACT
Debra L. Nelson, Chief Financial Officer Van Negris / Phillip J. Denning
Ibis Technology Corporation Kehoe, White, Savage & Co., Inc.
(978) 777 4247 (212) 888-1616
FOR IMMEDIATE RELEASE:
DR. JULIAN G. BLAKE JOINS IBIS TECHNOLOGY CORPORATION AS DIRECTOR OF TECHNOLOGY
DANVERS, MA -- APRIL 2, 1998 - Ibis Technology Corporation (Nasdaq:IBIS), the
leading supplier of SIMOX-SOI (Separation by Implantation of Oxygen /
Silicon-on-Insulator) wafers to the semiconductor industry, today announced
that Dr. Julian G. Blake has joined the Company as Director of Technology,
reporting to Martin J. Reid, President and Chief Executive Officer.
Dr. Blake has had an extensive career in ion implanter development and advanced
physics. During his 15 year tenure at Eaton Corporation, he was Technical
Director at the Eaton Flat Panel Division and Chief Scientist at the
Semiconductor Equipment Operations. Dr. Blake managed the engineering and
applications departments at Eaton which were responsible for the development of
a new ion implanter for active matrix display fabrication and thin film
deposition, as well as ion implantation products for semiconductor processing.
He was Principal Investigator for a $2,000,000 Air Force contract researching
SIMOX SOI technology and directed a low energy SIMOX development program. Dr.
Blake has served on the National Science Foundation Site Visit Committee (NCSU)
and the National Research Council (NAMAB), and holds seven U.S. patents. Prior
to joining Eaton Corporation, Dr. Blake worked for Exxon Solar Power
Corporation where he was responsible for the development of new solar cell
manufacturing processes. After receiving his Ph.D. in Applied Physics from
Harvard University in 1973, Dr. Blake spent another eight years with Harvard in
various capacities ranging from Physics lecturer to Director of the Gordon
McKay Laboratory.
Mr. Martin J. Reid, President and Chief Executive Officer, stated, "I am
pleased to announce Dr. Julian Blake's appointment as Director of Technology.
Julian brings an extensive range of experience in both ion implanters and
material science to Ibis. I am confident that his tenure at Ibis will result in
improvements to our existing implanters as well as the development of our next
generation of implanters and SIMOX products."
Ibis Technology Corporation is an advanced materials company which supplies
SIMOX-SOI wafers to the semiconductor industry and whose goal is to be the
world leader in volume manufacturing of SIMOX-SOI wafers. SIMOX-SOI wafers are
silicon on-insulator wafers which enable the production of integrated circuits
with significant advantages over circuits constructed on conventional bulk
silicon or epitaxial wafers. Ibis is promoting the global acceptance of
SIMOX-SOI wafers by continuing to develop advanced proprietary oxygen
implanters and process technology as well as by the formation of strategic
alliances.
"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF
1995: The statements contained in this press release which are not historical
fact are forward-looking statements based upon management's current
expectations that are subject to risks and uncertainties that could cause
actual results to differ materially from those set forth in or implied by
forward-looking statements, including, but not limited to, product demand and
market acceptance risks, general economic conditions, the impact of competitive
products, technologies and pricing, equipment capacity and supply constraints
or difficulties, the cyclical nature of the semiconductor industry, and other
risks described in the Company's Securities and Exchange Commission filings.
NOTE: Information about Ibis Technology Corporation and SIMOX-SOI is available
on Ibis's World Wide Web site on the Internet located at: http//www.ibis.com
# # #
IBIS TECHNOLOGY CORPORATION 32A Cherry Hill Drive Danvers, MA 01923
Telephone (978) 777-4247 or (978) 777-5051 Fax (978) 777 5570
